Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026)
Tarsus Pharmaceuticals (TARS) reported Receivables - Other of $1.67 million for Q3 2026, down 2.7% from $1.72 million a year earlier and down 26.8% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals posted Receivables - Other of $2.05 million, up 58.0% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of 152.5% (FY2020 to FY2025).
- By year, Receivables - Other came in at $1.3 million in FY2024 (+18.8%), $1.09 million in FY2023 (-69.5%), $3.58 million in FY2022 and $92,000 in FY2021 (+360.0%).
- The Q3 2026 figure ranks as the lowest quarterly Receivables - Other since Q4 2024.
- Year over year, Receivables - Other gained in seven of the last eight quarters, with growth averaging 135.3%.
- The high point for year-over-year Receivables - Other in five years was Q1 2026 (growth of 876.4%); the low point was Q1 2022 (a decline of 95.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.28 million (Q2 2026), $16.86 million (Q1 2026) and $2.05 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Tarsus Pharmaceuticals | 3.35 Bn | 2.41 Bn | 180.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.67 Mn |
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 246,000.00 |
| Mar 31, 2023 | 418,000.00 |
| Dec 31, 2022 | 3.58 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 603,000.00 |
| Mar 31, 2022 | 306,000.00 |
| Dec 31, 2021 | 92,000.00 |
API Access
Tarsus Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();